Back to results
US 8,956,625 B2Granted
Inactivated polio vaccines
AssigneeGlaxosmithkline Biologicals SA
InventorsHerve De Hemptinne, Michel Duchene, Anne Mary, Marc Sonveaux
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus are provided.
Claims20
A method of making a vaccine comprising diphtheria toxoid, tetanus toxoid and inactivated poliovirus type 1, comprising the steps of:
- mixing diphtheria toxoid and tetanus toxoid, followed by the addition of inactivated poliovirus (IPV) type 1 at a dose greater than 10 D-antigen units and less than 20 D-antigen units.
Dependencies are inferred from the claim text.